Thrombophilia
25
5
6
11
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.0%
1 terminated out of 25 trials
91.7%
+5.2% vs benchmark
8%
2 trials in Phase 3/4
9%
1 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (25)
Construction of a Multi-dimensional Risk Assessment System: a Clinical Study of Polycystic Ovary Syndrome Complicated With Thrombophilia
Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS Patients
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Fertility, Hypercoagulability, and Inflammation (FREYA) Registry
Hematological Disorders in EHPVO Patients
Longitudinal Cohort of Thrombosis and Hemostasis Diseases
Thrombophilia Assessment Under DOAC: Effectiveness of Activated Charcoal
Effect of DT56a (Femarelle) on the Coagulation System in the Treatment of Postmenopausal Women
Observational Dutch Young Symptomatic StrokE studY - nEXT
Thrombophilia Screening After Severe IUGR
Effect of Prophylatic Use of Enoxaparin in Women Undergoing in Vitro Fertilization Treatment
Investigating the Involvement of ACE and Angiotensinogen Genes' Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic Events
Acute Phase Reactions and Thrombophilia in Pediatric Patients With Migraine
EFFects of Thrombophilia on the Outcomes of Assisted Reproduction Technologies
Evaluation of Precision and Accuracy of INR Measurements in a Point of Care Device (OPTIMAL)
Thrombin Generation and Gestational Outcome
A Comparison of Sequential Compression Devices and Foot Pumps in the Obstetric Population
Prevalence of Clinical and Laboratory Markers of Hypofibrinolysis in Psychotic Patients
TIPPS: Thrombophilia in Pregnancy Prophylaxis Study
Guilford Genomic Medicine Initiative (GGMI)